$1.67
0.010.60%
At Close: -
$1.67
00.00%
After Hours: 7:58 PM EDT
15 minutes delayed
Lexicon Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lexicon Pharmaceuticals using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
LXRX | Lexicon Pharmaceuticals | -$0.22 | — | — | — | $317.00K | — | — | — | 08/01/2024 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.17 | -$0.20 | -$0.20 | — | $24.00K | $1.37M | $1.13M | -17.52% | 05/02/2024 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.22 | -$0.20 | 9.09% | $28.00K | $1.24M | $702.00K | -43.39% | 03/11/2024 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.13 | -$0.21 | -$0.21 | 0.00% | $39.00K | $2.06M | $162.00K | -92.14% | 11/08/2023 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.17 | -$0.22 | -29.41% | $35.00K | $70.00K | $317.00K | 352.86% | 08/03/2023 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.18 | -$0.17 | 5.56% | $37.00K | $30.00K | $24.00K | -20.00% | 05/02/2023 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.17 | -$0.13 | -$0.16 | -23.08% | $14.00K | $50.00K | $28.00K | -44.00% | 03/02/2023 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.14 | -$0.13 | 7.14% | $23.00K | $50.00K | $39.00K | -22.00% | 11/09/2022 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.13 | -$0.16 | -$0.16 | 0.00% | $234.00K | $50.00K | $35.00K | -30.00% | 08/02/2022 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.15 | -$0.16 | -$0.16 | 0.00% | $27.00K | $50.00K | $37.00K | -26.00% | 05/05/2022 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.04 | -$0.18 | -$0.17 | 5.56% | $199.00K | — | $14.00K | — | 02/28/2022 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.43 | -$0.18 | -$0.16 | 11.11% | $6.63M | — | $23.00K | — | 11/03/2021 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.65 | -$0.16 | -$0.13 | 18.75% | $9.16M | $10.00K | $234.00K | 2240.00% | 07/30/2021 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.63 | -$0.16 | -$0.15 | 6.25% | $8.00M | $1.68M | $27.00K | -98.39% | 05/06/2021 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.48 | -$0.28 | -$0.04 | 85.71% | $8.73M | $110.00K | $199.00K | 80.91% | 03/10/2021 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.10 | $0.26 | -$0.43 | -265.38% | $294.45M | $16.87M | $6.63M | -60.68% | 10/29/2020 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.22 | -$0.61 | -$0.65 | -6.56% | $9.68M | $8.83M | $9.16M | 3.77% | 07/30/2020 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.21 | -$0.69 | -$0.63 | 8.70% | $9.22M | $7.79M | $8.00M | 2.68% | 04/27/2020 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.77 | -$0.48 | 37.66% | $17.07M | $10.26M | $8.73M | -14.94% | 03/12/2020 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.26 | $0.73 | -$0.10 | -113.70% | $6.86M | $64.25M | $294.45M | 358.28% | 11/07/2019 | Get Alert |
LXRX | Lexicon Pharmaceuticals | -$0.33 | -$0.08 | -$0.22 | -175.00% | $13.75M | $28.52M | $9.68M | -66.05% | 07/31/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-03-11 | $-0.20 | $-0.22 | 9.09 % |
Sep 2023 | 2023-11-08 | $-0.21 | $-0.21 | 0.00 % |
Jun 2023 | 2023-08-03 | $-0.22 | $-0.17 | -29.4 % |
Mar 2023 | 2023-05-02 | $-0.17 | $-0.18 | 5.56 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-02 | $1.13M | $1.37M | -17.5 % |
Dec 2023 | 2024-03-11 | $702.00K | $1.24M | -43.4 % |
Sep 2023 | 2023-11-08 | $162.00K | $2.06M | -92.1 % |
Jun 2023 | 2023-08-03 | $317.00K | $70.00K | 352.9 % |
Lexicon Pharmaceuticals (LXRX) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on May 2, 2024 for Q1.
The Actual EPS was $-0.20, which hit the estimate of $-0.20.
The Actual Revenue was $1.1M, which missed the estimate of $1.4M.
Browse earnings estimates, EPS, and revenue on all stocks.